Symposium View On Demand Website Slider

Did you miss out on 'attending'

the Parkinson's Australia

National Symposium?

You can still register to access the

'View on Demand' videos of the presentations



Parkinson’s Australia is pleased to announce that the long standing shortage of a formulation of Levodopa/Carbidopa 200/50 (Sinemet CR) has been resolved.


The manufacturers, MSD (Merck, Sharp & Dohme) Australia, have announced that this medication is once again available. The only change is that Sinemet CR will now be packed in a bottle containing 100 tablets as opposed to the previous packaging in a blister pack containing 60 tablets.


Naturally any queries about prescribing of this medication should be directed to your treating medical specialist.

Subscribe to our mailing list to receive our quarterly newsletter

The content of this web site is intended to convey general educational information and should not be relied upon as a substitute for professional healthcare advice. 

© 2020 by Parkinson's Australia, PO Box 108, Deakin West, ACT 2600

ABN 46 011 714 078   

Parkinson's Australia Privacy Policy